NCT05563766
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05563766
Title A Phase II Trial to Evaluate the Effect of Itraconazole on Pathologic Complete Response Rates in Resectable Esophageal Cancer
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors VA Office of Research and Development
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
VA Palo Alto Health Care System, Palo Alto, CA RECRUITING Palo Alto California 94304-1207 United States Details
VA Ann Arbor Healthcare System, Ann Arbor, MI RECRUITING Ann Arbor Michigan 48105-2303 United States Details
Durham VA Medical Center, Durham, NC RECRUITING Durham North Carolina 27705-3875 United States Details
VA Portland Health Care System, Portland, OR RECRUITING Portland Oregon 97207-2964 United States Details
VA North Texas Health Care System Dallas VA Medical Center, Dallas, TX RECRUITING Dallas Texas 75216-7167 United States Details
Michael E. DeBakey VA Medical Center, Houston, TX RECRUITING Houston Texas 77030-4211 United States Details
VA Puget Sound Health Care System Seattle Division, Seattle, WA RECRUITING Seattle Washington 98108-1532 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field